Company

Eradivir

Biotechnology Research West Lafayette, In, United States 22 employees

Employees: 22
Contacts: 2
Emails: 2
Phones: 1

www.eradivir.com LinkedIn Crunchbase

Eradivir Overview

Headquarters: West Lafayette, In, United States
Website: www.eradivir.com
Industry: Biotechnology Research
Employees: 22
Founded: 2020
Funding: 9.8M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

- Science In Action

About Eradivir

Eradivir’s founder, Dr. Philip S. Low, has successfully developed multiple FDA-approved targeted small molecules. These therapies all function by attaching various payloads to ligands, which bind with high specificity to diseased cells. Examples of approved molecules include a radiotherapy drug for prostate cancer and an intraoperative imaging agent for lung and ovarian cancers. Several others are currently in clinical trials (e.g., treatments for cancer, malaria, and sickle cell anemia). Eradivir was founded in March 2020 to advance a promising application of this platform in combating multiple disease states, initially focusing on influenza and other respiratory infections.

Eradivir Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Eradivir Org Chart

Sample employees and titles

Name	Title	Location	Contact
Conrrad Nicholls, Phd, Mph	Associate Director - Virology		View
Imrul Shahriar	Associate Director - Oncology		View
Philip Low	Presidential Scholar for Drug Discovery	West Lafayette, Indiana, United States	Email Phone
Thomas Wilkinson	Multiplying Value, Elevating Minds	Salt Lake City Metropolitan Area, United States	Email